Citigroup’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-449
| Closed | -$179 | – | 5143 |
|
|
2022
Q4 | $179 | Buy |
449
+22
| +5% | +$9 | ﹤0.01% | 4802 |
|
|
2022
Q3 | $0 | Sell |
427
-716
| -63% | – | ﹤0.01% | 5691 |
|
|
2022
Q2 | $3K | Sell |
1,143
-27
| -2% | -$71 | ﹤0.01% | 5036 |
|
|
2022
Q1 | $7K | Sell |
1,170
-3,596
| -75% | -$21.5K | ﹤0.01% | 4919 |
|
|
2021
Q4 | $53K | Buy |
4,766
+2,951
| +163% | +$32.8K | ﹤0.01% | 4274 |
|
|
2021
Q3 | $30K | Buy |
1,815
+1,068
| +143% | +$17.7K | ﹤0.01% | 4290 |
|
|
2021
Q2 | $14K | Buy |
747
+300
| +67% | +$5.62K | ﹤0.01% | 4843 |
|
|
2021
Q1 | $7K | Sell |
447
-577
| -56% | -$9.04K | ﹤0.01% | 5162 |
|
|
2020
Q4 | $33K | Buy |
+1,024
| New | +$33K | ﹤0.01% | 4351 |
|